{"id":13212,"date":"2024-07-16T15:38:28","date_gmt":"2024-07-16T13:38:28","guid":{"rendered":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/?p=13212"},"modified":"2024-07-16T15:39:24","modified_gmt":"2024-07-16T13:39:24","slug":"self-assembling-dendrimer-nanosystems-for-specific-fluorine-magnetic-resonance-imaging-and-effective-theranostic-treatment-of-tumors","status":"publish","type":"post","link":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/2024\/07\/16\/self-assembling-dendrimer-nanosystems-for-specific-fluorine-magnetic-resonance-imaging-and-effective-theranostic-treatment-of-tumors\/","title":{"rendered":"Self-assembling dendrimer nanosystems for specific fluorine magnetic resonance imaging and effective theranostic treatment of tumors"},"content":{"rendered":"<p><em>Proc. Natl. Acad. Sci. U.S.A. <\/em><strong>2024<\/strong>, <em>121<\/em>, e2322403121. DOI: 10.1073\/pnas.2322403121.<\/p>\n<p>Zhenbin LYU<sup>1,2,#<\/sup>, Brigino RALAHY<sup>1,#<\/sup>, Teodora-Adriana PERLES-BARBACARU<sup>3,#<\/sup>, Ling DING<sup>1,3,#<\/sup>, Yifan JIANG<sup>1<\/sup>, Baoping LIAN<sup>4<\/sup>, Tom ROUSSEL<sup>1<\/sup>, Xi LIU<sup>1,5<\/sup>, Christina GALANAKOU<sup>1<\/sup>, Erik LAURINI<sup>6<\/sup>, Aura TINTARU<sup>2<\/sup>, Suzanne GIORGIO<sup>1<\/sup>, Sabrina PRICL<sup>6,7<\/sup>, Xiaoxuan LIU<sup>4<\/sup>, Monique BERNARD<sup>3<\/sup>, Juan IOVANNA<sup>5<\/sup>, Ang\u00e8le VIOLA<sup>3<\/sup>, Ling PENG<sup>1<\/sup><\/p>\n<p>Fluorine magnetic resonance imaging (<sup>19<\/sup>F-MRI) is particularly promising for biomedical applications owing to the absence of fluorine in most biological systems. However, its use has been limited by the lack of safe and water-soluble imaging agents with high fluorine contents and suitable relaxation properties. Because agents with high fluorine contents are both hydrophobic and lipophobic, they tend to be heavily aggregated and poorly soluble in water, impeding the mobility of <sup>19<\/sup>F nuclei and therefore attenuating the <sup>19<\/sup>F-MRI signal.<\/p>\n<p>In this paper, the authors report innovative <sup>19<\/sup>F-MRI agents based on dendrimer nanosystems formed by self-assembly of an amphiphilic dendrimer composed of a hydrophobic alkyl chain and a hydrophilic dendron (Figure 1A). This amphiphilic dendrimer <strong>1c<\/strong> (Figure 1B) bears multiple negatively charged terminals with high fluorine content, which effectively prevented intra- and intermolecular aggregation of fluorinated entities via electrostatic repulsion. This permitted high mobility of fluorine nuclei alongside good water solubility with favorable relaxation properties for use in <sup>19<\/sup>F-MRI. Importantly, the self-assembling <sup>19<\/sup>F-MRI agent was able to encapsulate the near-infrared fluorescence (NIRF) agent and the anticancer drug for multimodal <sup>19<\/sup>F-MRI and NIRF imaging and theranostic treatment of cancer, with efficacy largely outperforming the clinical anticancer drug.<\/p>\n<p>Specifically, the amphiphilic dendrimer <strong>1c<\/strong> self-assembled spontaneously in water into small and uniform nanomicelles <strong>1c<\/strong>@ (Figure 2A\/B).\u00a0 The formed nanomicelles <strong>1c<\/strong>@ gave a very sharp and intense <sup>19<\/sup>F-NMR peak in water (Figure 2C), highlighting the excellent the mobility of <sup>19<\/sup>F nuclei. In addition, <strong>1c<\/strong>@ had favorable relaxation time constants (Figure 2D) with effective in vitro <sup>19<\/sup>F-MRI (Figure 2E) and specific cancer detection in tumor-bearing mice (Figure 2F\/G).<\/p>\n<p>In addition, the authors encapsulated the hydrophobic NIRF dye DiR and the anticancer drug paclitaxene (PTX) within the nanomicelles <strong>1c<\/strong>@ for multimodality imaging and theranostic treatment of pancreatic cancer in a patient-derived pancreatic cancer model. The obtained PTX\/DiR\/<strong>1c<\/strong>@ nanomieclles had high drug loading (23%), and similar size and morphology as <strong>1c<\/strong>@ (Figure 3A). Also, PTX\/DiR\/<strong>1c<\/strong>@ displayed similar NIRF as the fluorescent DiR (Figure 3B), and its <sup>19<\/sup>F-MRI properties resembled those of <strong>1c<\/strong>@ with relaxation time constants allowing similar <sup>19<\/sup>F-MRI detectability (Figure 3C). Both NIRF imaging (Figure 3D) and <sup>19<\/sup>F-MRI (Figure 3E) showed the presence of PTX\/DiR\/<strong>1c<\/strong>@ in the tumors, confirming the performance of PTX\/DiR\/<strong>1c<\/strong>@ as a dual <sup>19<\/sup>F-MRI and NIRF imaging agent.<\/p>\n<p>Furthermore, mice treated with PTX\/DiR\/<strong>1c<\/strong>@ showed markedly inhibited tumor growth, compared to a non-significant inhibition in those treated with the equivalent dose of non-encapsulated PTX (Figure 3F). Effective anticancer activity was further confirmed using PTX\/<strong>1c<\/strong>@ at an even lower PTX dose of 3.0 mg\/kg (Figure 3G). The superior anticancer activities of both PTX\/<strong>1c<\/strong>@ and PTX\/DiR\/<strong>1c<\/strong>@ over the free drug PTX can be ascribed to the EPR-based passive tumor targeting obtained by encapsulation of the drug within the nanoparticles. The resulting increase in the accumulation and local concentration of the drug within the tumor significantly improves treatment efficiency.<\/p>\n<p>In summary, the innovative self-assembling fluorinated dendrimer nanosystems are effective for <sup>19<\/sup>F-MRI, <sup>19<\/sup>F-MRI-based multimodal imaging and theranostic treatment of tumors. In personalized medicine, this approach can be adapted to the construction of modular nanosystems for the required multimodal imaging and theranostics, enabling targeted delivery of patient-specific pharmaceutical agents and image-based monitoring of their efficacy. This concept of modular nanosystems issued from self-assembling supramolecular dendrimers is an innovative approach providing a platform for the encapsulation of imaging agents and therapeutics for <sup>19<\/sup>F-MRI-based multimodal theranostics for improved treatment efficiency and monitoring.<\/p>\n<p><strong>Fig. 1 <\/strong>Schematic illustration of self-assembling supramolecular dendrimer nanosystems for fluorine magnetic resonance imaging (<sup>19<\/sup>F-MRI), <sup>19<\/sup>F-MRI-based multimodal imaging and theranostics. (A) Self-assembly of a fluorinated amphiphilic dendrimer into nanomicelles in the absence and\/or presence of the NIRF probe DiR and the anticancer drug paclitaxel (PTX) within the supramolecular dendrimer core for <sup>19<\/sup>F-MRI, bimodal <sup>19<\/sup>F-MRI and NIRF imaging as well as <sup>19<\/sup>F-MRI-based theranostics for cancer detection and treatment. (B) Chemical structures of the amphiphilic dendrimer <strong>1c <\/strong>designed and studied for <sup>19<\/sup>F-MRI.<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-13213\" src=\"https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure1-1-236x300.png\" alt=\"\" width=\"236\" height=\"300\" srcset=\"https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure1-1-236x300.png 236w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure1-1-807x1024.png 807w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure1-1-768x975.png 768w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure1-1.png 1006w\" sizes=\"(max-width: 236px) 100vw, 236px\" \/><\/p>\n<p><strong>Fig. 2<\/strong> Self-assembling of the amphiphilic dendrimer <strong>1c<\/strong> into nanomicelles <strong>1c<\/strong>@ for use as an imaging agent for fluorine magnetic resonance imaging (<sup>19<\/sup>F-MRI). (A) Dynamic light scattering results and (B) transmission electron microscopy image of the self-assembled <strong>1c<\/strong>@ nanomicelles. (C) <sup>19<\/sup>F-NMR spectrum of<strong> 1c<\/strong>@ in D<sub>2<\/sub>O. (D) <sup>19<\/sup>F magnetic resonance relaxation time constants (T<sub>1<\/sub> and T<sub>2<\/sub>) for <strong>1c<\/strong>@ at a magnetic field strength of 7 T and 20\u00b0C. (E) <em>In vitro<\/em> <sup>19<\/sup>F-MR images of <strong>1c<\/strong>@ at four different concentrations. (F, G) <em>In vivo <\/em><sup>1<\/sup>H-MR anatomical images (top), <sup>19<\/sup>F-MR images (middle), and overlay of <sup>1<\/sup>H-MR and <sup>19<\/sup>F-MR images (bottom) of tumors in pancreatic cancer xenograft mice 24 h after intravenous injection of <strong>1c<\/strong>@ at <strong>1c <\/strong>concentrations of (F) 0.208 mmol\/kg and (G) 0.104 mmol\/kg (corresponding to fluorine concentrations of 5.00 and 2.50 mmol\/kg, respectively). MR images were acquired in the sagittal plane with respect to the mouse.<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-13215\" src=\"https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure2-1-286x300.png\" alt=\"\" width=\"286\" height=\"300\" srcset=\"https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure2-1-286x300.png 286w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure2-1-975x1024.png 975w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure2-1-768x807.png 768w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure2-1.png 1035w\" sizes=\"(max-width: 286px) 100vw, 286px\" \/><\/p>\n<p><strong>Fig. 3 <\/strong>The anticancer drug paclitaxel (PTX) and the near-infrared fluorescence (NIRF) dye DiR encapsulated within <strong>1c<\/strong>@ for <sup>19<\/sup>F-MRI-based multimodal imaging and theranostic treatment of tumor in pancreatic cancer xenograft mice. (A) Transmission electron microscopy image of PTX\/DiR\/<strong>1c<\/strong>@. (B) Normalized fluorescence emission spectrum of PTX\/DiR\/<strong>1c<\/strong>@. (C) <em>In vitro<\/em> <sup>19<\/sup>F-MR images of PTX\/DiR\/<strong>1c<\/strong>@. (D) <em>In vivo<\/em> NIRF imaging of pancreatic cancer xenograft mice 48 h after injection of PTX\/DiR\/<strong>1c<\/strong>@. (E) <sup>19<\/sup>F-MRI superimposed on anatomic <sup>1<\/sup>H-MRI of tumors in pancreatic cancer xenograft mice 48 h after accomplished treatment with of PTX\/DiR\/<strong>1c<\/strong>@. MR images were acquired in the sagittal plane with respect to the mouse. (F, G) Tumor growth inhibition in tumor-xenograft mice following intravenous injection of (F) PTX\/DiR\/<strong>1c<\/strong>@ at a PTX concentration of 7.5 mg\/kg or (G) PTX\/<strong>1c<\/strong>@ at a PTX concentration of 3.0 mg\/kg twice per week for 2 weeks. Statistical differences were assessed using two-way ANOVA with Tukey\u2019s multiple comparison test.<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-13217\" src=\"https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure3-1-300x285.png\" alt=\"\" width=\"300\" height=\"285\" srcset=\"https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure3-1-300x285.png 300w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure3-1-1024x974.png 1024w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure3-1-768x731.png 768w, https:\/\/www.cinam.univ-mrs.fr\/cinam\/wp-content\/uploads\/2024\/07\/Figure3-1.png 1068w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new publication in IMMF Department<\/p>\n","protected":false},"author":16,"featured_media":13200,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[31],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/posts\/13212"}],"collection":[{"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/comments?post=13212"}],"version-history":[{"count":2,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/posts\/13212\/revisions"}],"predecessor-version":[{"id":13220,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/posts\/13212\/revisions\/13220"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/media\/13200"}],"wp:attachment":[{"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/media?parent=13212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/categories?post=13212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cinam.univ-mrs.fr\/cinam\/en\/wp-json\/wp\/v2\/tags?post=13212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}